Author
Listed:
- Dimos Chatzinikolaou
(Department of Economics, Democritus University of Thrace, 69100 Komotini, Greece
School of Business, University of Nicosia, P.O. Box 24005, CY-2417 Nicosia, Cyprus
Knowledge Management, Innovation and Strategy Center (KISC), University of Nicosia, P.O. Box 24005, CY-2417 Nicosia, Cyprus)
- Nefeli-Maria Magaliou
(School of Business, University of Nicosia, P.O. Box 24005, CY-2417 Nicosia, Cyprus)
- Charis Michael Vlados
(Department of Economics, Democritus University of Thrace, 69100 Komotini, Greece
School of Business, University of Nicosia, P.O. Box 24005, CY-2417 Nicosia, Cyprus
Knowledge Management, Innovation and Strategy Center (KISC), University of Nicosia, P.O. Box 24005, CY-2417 Nicosia, Cyprus)
Abstract
This study examines how strategic human resource management (SHRM) practices in pharmaceutical multinational enterprises (MNEs) operating in Greece are influenced by digital innovation and social dialogue. Structured questionnaires were distributed to 82 participants across seven large pharmaceutical MNEs in Greece, using purposive and stratified sampling to capture perspectives from senior managers, middle managers, and specialized employees. Findings indicate that while digital tools are present in SHRM systems, their integration remains functional rather than strategic. Social dialogue mechanisms exist but exert limited influence on decision-making. The study proposes that SHRM models—economies like Greece (characterized by medium-level competitiveness performance)—must be recontextualized to account for organizational learning capacities, and the strategic alignment between innovation, management, and social dialogue. We suggest that MNEs in the pharmaceutical sector should invest in integrated SHRM systems that prioritize cross-functional collaboration, localized adaptability, and participatory governance.
Suggested Citation
Dimos Chatzinikolaou & Nefeli-Maria Magaliou & Charis Michael Vlados, 2025.
"Strategic Human Resource Management, Innovation, and Social Dialogue in the Fourth Industrial Revolution: The Case of Greek Pharmaceutical Multinationals,"
Societies, MDPI, vol. 15(8), pages 1-16, August.
Handle:
RePEc:gam:jsoctx:v:15:y:2025:i:8:p:228-:d:1726614
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jsoctx:v:15:y:2025:i:8:p:228-:d:1726614. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.